HK1023342A1 - Substituted isoquinolines as ultra short acting neuromuscular blockers - Google Patents

Substituted isoquinolines as ultra short acting neuromuscular blockers

Info

Publication number
HK1023342A1
HK1023342A1 HK00102447A HK00102447A HK1023342A1 HK 1023342 A1 HK1023342 A1 HK 1023342A1 HK 00102447 A HK00102447 A HK 00102447A HK 00102447 A HK00102447 A HK 00102447A HK 1023342 A1 HK1023342 A1 HK 1023342A1
Authority
HK
Hong Kong
Prior art keywords
short acting
ultra short
neuromuscular blockers
substituted isoquinolines
acting neuromuscular
Prior art date
Application number
HK00102447A
Other languages
English (en)
Inventor
Eric Cleveland Bigham
Eric Eugene Boros
Grady Evan Boswell
Robert Anthony Mook Jr
Sanjay Shashikant Patel
Vincente Samano
John Joseph Savarese
Roy Archibald Swaringen Jr
Original Assignee
Avera Pharmaceuticals Inc
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed by Avera Pharmaceuticals Inc, Cornell Res Foundation Inc filed Critical Avera Pharmaceuticals Inc
Publication of HK1023342A1 publication Critical patent/HK1023342A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
HK00102447A 1997-03-25 2000-04-25 Substituted isoquinolines as ultra short acting neuromuscular blockers HK1023342A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers
PCT/EP1998/001651 WO1998042674A1 (en) 1997-03-25 1998-03-23 Substituted isoquinolines as ultra short acting neuromuscular blockers

Publications (1)

Publication Number Publication Date
HK1023342A1 true HK1023342A1 (en) 2000-09-08

Family

ID=26311255

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00102447A HK1023342A1 (en) 1997-03-25 2000-04-25 Substituted isoquinolines as ultra short acting neuromuscular blockers

Country Status (37)

Country Link
US (2) US6177445B1 (de)
EP (4) EP1526130A1 (de)
JP (3) JP4112016B2 (de)
KR (2) KR100578443B1 (de)
CN (1) CN1203061C (de)
AP (1) AP1797A (de)
AR (1) AR012156A1 (de)
AT (3) ATE254107T1 (de)
AU (2) AU6730598A (de)
BR (1) BR9808422B1 (de)
CA (1) CA2284802C (de)
CO (1) CO4940499A1 (de)
CZ (1) CZ293786B6 (de)
DE (3) DE69840816D1 (de)
DK (2) DK0975599T3 (de)
EA (1) EA002224B1 (de)
EE (1) EE04113B1 (de)
ES (2) ES2242275T3 (de)
HK (1) HK1023342A1 (de)
HR (1) HRP980157B1 (de)
HU (1) HU228230B1 (de)
ID (1) ID22901A (de)
IL (1) IL131918A (de)
IS (2) IS2346B (de)
MA (1) MA26476A1 (de)
MY (1) MY121316A (de)
NO (1) NO314726B1 (de)
NZ (1) NZ337797A (de)
PE (1) PE68399A1 (de)
PL (1) PL190860B1 (de)
PT (2) PT975599E (de)
RS (1) RS49869B (de)
SI (1) SI0975599T1 (de)
TR (1) TR199902330T2 (de)
TW (1) TW505635B (de)
UY (1) UY24933A1 (de)
WO (2) WO1998042674A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203061C (zh) * 1997-03-25 2005-05-25 艾弗拉药品公司 取代异喹啉类,其制备方法,药物组合物及其制药用途
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
EP1684753A2 (de) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuskuläre blockiermittel und ihre antagonisten
WO2008070121A1 (en) 2006-12-06 2008-06-12 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
WO2008107887A2 (en) 2007-03-08 2008-09-12 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
WO2008117271A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
EP2155684B1 (de) * 2007-05-01 2014-04-09 Chemagis Ltd. Verfahren zur herstellung von cisatracuriumverbindungen und damit assoziierte zwischenprodukte
EP2142510A1 (de) 2007-05-01 2010-01-13 Chemagis Ltd. Neuartige isochinolin-verbindungen zur herstellung von cisatracurium und entsprechenden zwischenprodukten
US8357805B2 (en) * 2007-06-18 2013-01-22 Chemagis Ltd. (1R,1′R)-atracurium salts separation process
EP2176227A1 (de) * 2007-07-09 2010-04-21 Chemagis Ltd. Verfahren zur herstellung von cisatracurium und zugehörige zwischenprodukte
AU2008320380A1 (en) 2007-10-29 2009-05-07 Chemagis Ltd. Novel R,R'-atracurium salts
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (zh) 2009-08-19 2017-03-15 康奈尔大学 供生理注射用的半胱氨酸
EP2867219B1 (de) * 2012-06-29 2017-02-15 Cornell University Asymmetrische reversible neuromuskuläre blockiermittel von sehr kurzen, kurzer oder mittellanger dauer
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
WO2021115413A1 (zh) * 2019-12-11 2021-06-17 江苏恒瑞医药股份有限公司 神经肌肉阻滞剂及其制备方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成(r)-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
IL55254A (en) * 1977-08-01 1983-03-31 Massachusetts Gen Hospital Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
CN1203061C (zh) * 1997-03-25 2005-05-25 艾弗拉药品公司 取代异喹啉类,其制备方法,药物组合物及其制药用途

Also Published As

Publication number Publication date
SI0975599T1 (en) 2004-04-30
AU6730598A (en) 1998-10-20
US6187789B1 (en) 2001-02-13
CZ293786B6 (cs) 2004-07-14
BR9808422A (pt) 2000-05-23
IS2346B (is) 2008-03-15
DK0975599T3 (da) 2004-03-15
EP0971898B1 (de) 2005-05-11
KR100578443B1 (ko) 2006-05-11
CZ340499A3 (cs) 2000-04-12
HU228230B1 (en) 2013-02-28
HUP0001556A2 (hu) 2001-04-28
PT971898E (pt) 2005-07-29
PL335885A1 (en) 2000-05-22
IL131918A (en) 2005-09-25
WO1998042674A1 (en) 1998-10-01
ES2242275T3 (es) 2005-11-01
ES2210757T3 (es) 2004-07-01
EP0971898A1 (de) 2000-01-19
EP1380573B1 (de) 2009-05-06
US6177445B1 (en) 2001-01-23
EP0975599A1 (de) 2000-02-02
PT975599E (pt) 2004-03-31
HUP0001556A3 (en) 2002-01-28
NO314726B1 (no) 2003-05-12
MA26476A1 (fr) 2004-12-20
EA199900756A1 (ru) 2000-08-28
AR012156A1 (es) 2000-09-27
NO994680D0 (no) 1999-09-24
WO1998042675A1 (en) 1998-10-01
HRP980157B1 (en) 2004-10-31
CA2284802A1 (en) 1998-10-01
AP9901658A0 (en) 1999-09-30
DE69830157D1 (de) 2005-06-16
KR100554601B1 (ko) 2006-03-03
EE9900424A (et) 2000-04-17
ATE430734T1 (de) 2009-05-15
UY24933A1 (es) 2000-12-29
IS5185A (is) 1999-09-17
IL131918A0 (en) 2001-03-19
CN1257483A (zh) 2000-06-21
AU745382B2 (en) 2002-03-21
EP1380573A3 (de) 2004-01-21
ATE295351T1 (de) 2005-05-15
EP1526130A1 (de) 2005-04-27
JP4112015B2 (ja) 2008-07-02
DE69819703T2 (de) 2004-09-30
JP2008019272A (ja) 2008-01-31
NO994680L (no) 1999-11-24
ATE254107T1 (de) 2003-11-15
ID22901A (id) 1999-12-16
CO4940499A1 (es) 2000-07-24
BR9808422B1 (pt) 2010-08-24
NZ337797A (en) 2001-03-30
HRP980157A2 (en) 1999-02-28
JP2002503220A (ja) 2002-01-29
CA2284802C (en) 2009-06-16
DE69840816D1 (de) 2009-06-18
DE69830157T2 (de) 2006-05-11
JP4112016B2 (ja) 2008-07-02
TR199902330T2 (xx) 2000-02-21
AU7521098A (en) 1998-10-20
DK0971898T3 (da) 2005-09-05
IS8717A (is) 2008-03-03
MY121316A (en) 2006-01-28
EP0975599B1 (de) 2003-11-12
RS49869B (sr) 2008-08-07
EP1380573A2 (de) 2004-01-14
TW505635B (en) 2002-10-11
CN1203061C (zh) 2005-05-25
KR20050103984A (ko) 2005-11-01
PE68399A1 (es) 1999-07-23
DE69819703D1 (de) 2003-12-18
YU48399A (sh) 2002-06-19
EE04113B1 (et) 2003-08-15
EA002224B1 (ru) 2002-02-28
JP2002517168A (ja) 2002-06-11
PL190860B1 (pl) 2006-02-28
AP1797A (en) 2007-11-15
KR20010005621A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
HK1023342A1 (en) Substituted isoquinolines as ultra short acting neuromuscular blockers
IL132192A0 (en) Substituted 3-cyano quinolines
GB9717660D0 (en) Mobile crane
HK1025189A1 (en) Switching coaxial jack
GB9721964D0 (en) Isoquinolines
GB9816228D0 (en) Isoquinolines
GB9625294D0 (en) Overhead boom arrangement
GB9706117D0 (en) Ultra-short acting neuromuscular blockers
GB9724987D0 (en) Ultra-short acting neuromuscular blockers
GB2339313B (en) Terminal
HK1023551A1 (en) Crane
GB9917247D0 (en) Hidden electrical switch
AU132253S (en) Terminal
AU129782S (en) Mobile clothes airer
GB2331448B (en) Stockings
GB9713163D0 (en) Mineral breaker
TW327974U (en) Safety clothes
GB2324022B (en) Interlinked watchstrap
KR200165840Y1 (en) Terminal structure
TW383897U (en) Horizontal swaying switch
IL155605A0 (en) Substituted pyridines as anti-hyperlipoproteinemic agents
AU136179S (en) Mobile clothes airer
GB9600339D0 (en) Safety garment
TW343801U (en) Continuous terminal pin
IL140168A0 (en) Isoquinolines as urokinase

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: CORNELL RESEARCH FOUNDATION INC.

Free format text: FORMER OWNER(S): GLAXO GROUP LIMITED, CORNELL RESEARCH FOUNDATION INC

Owner name: AVERA PHARMACEUTICALS, INC.

Free format text: FORMER OWNER(S): GLAXO GROUP LIMITED, CORNELL RESEARCH FOUNDATION INC

PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140323